EnlightenBio-Logo-Reverse

Quest Diagnostics Granted CDC Contract to Sequence COVID-19 Gene Variants to Aid Public Health Response to COVID-19

Quest’s genomic sequencing and infectious disease expertise will identify novel SARS-CoV-2 mutations, providing insights on prevalence and transmission in the United States SECAUCUS, N.J., Jan. 18...read more

Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML)

Project aims to standardize MRD data generation, assessment and accelerate AML clinical trial programs bringing novel therapies to patients in need faster SAN FRANCISCO, Jan. 14, 2021 /PRNewswire/ — Invitae...read more

Pacific Biosciences and Invitae to Develop Ultra-High-Throughput Clinical Whole Genome Sequencing Platform

New platform expected to make whole genome sequencing significantly more affordable and accessible for use in mainstream medical care MENLO PARK, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of...read more

EnlightenBio-Logo-Reverse

Brigitte Ganter

Quest Diagnostics Granted CDC Contract to Sequence COVID-19 Gene Variants to Aid Public Health Response to COVID-19

Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML)

Pacific Biosciences and Invitae to Develop Ultra-High-Throughput Clinical Whole Genome Sequencing Platform

ADVERTISEMENT

Recent posts

The Promise and Hope of RNA-based vaccines for COVID-19

Gene Editing Revamped with CRISPR Prime Editor – Result Is A High Efficiency, More Precise Gene Editor With Versatile Editing Capabilities And Lower Off-Target Effects

An interview with Michael Snyder, Stanford W. Ascherman Professor and Chair, Department of Genetics & Director, Center for Genomics and Personalized Medicine

Nebion Provides Curated Omics Data Combined with Innovative Visualizations for Target Discovery, Indication Finding, and Drug Safety Assessment

Mike Pellini, Section 32: “I hope we will find a way where the payers and the healthcare industry will work much more closely together to generate the data that will ultimately be useful in answering difficult, cost-based decisions.”

Othram Aims to Overcome DNA Sequencing Challenges to Solve Forensic Crime Cases

Follow Me

Most popular

Quest Diagnostics Granted CDC Contract to Sequence COVID-19 Gene Variants to Aid Public Health Response to COVID-19

Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML)

Pacific Biosciences and Invitae to Develop Ultra-High-Throughput Clinical Whole Genome Sequencing Platform

Personal Genome Diagnostics and QIAGEN Collaborate to Offer Integrated Genomic Testing and Interpretation Support

The Promise and Hope of RNA-based vaccines for COVID-19

Delfi Diagnostics Announces $100 Million Series A Financing to Develop a New Class of Early Detection Liquid Biopsy for Multiple Cancers

NuProbe Closes $42M Fundraising

Helix® Laboratory Platform Granted the First and Only FDA Authorization for a Whole Exome Sequencing Platform

QIAGEN Announces Global Distribution Agreement for the COSMIC Database from the Wellcome Sanger Institute

Pharmacogenetic and Genealogy Pioneers Merge for Historic Partnership

Illumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK Variant (B.1.1.7) in the US and Develop National Surveillance Infrastructure

Most discussed

Genohm Aims to Hit the Sweet Spot With a Customizable SLIMS + ELN Solution for Lab Information Management

Just Released – Our New Clinical NGS Process Report

Genomenon’s Automated Genomic Search Engine Mastermind Illuminates Current Trends in Genomic Literature – A Look at the Top Cited Variants Across the Scientific Literature

The JP Morgan Healthcare Conference from Afar

Immunotherapy and the Basis of Neoantigen Biology: Part I Neoantigens

Nebula Genomics’ Goal Is To Make The Value of Genome Sequencing a Reality

The Life of a Genetic Counselor: Providing Patient Education, Navigating Insurance, and Challenges in Choosing Tests

Review of Emerging 2018 Genomic Variants – a Genomenon Research Report

PMWC 2016 Silicon Valley: Scalable Clinical Data Interpretation The Biggest Bottleneck

EnlightenBio-Logo-Reverse

Brigitte Ganter

You may also like

ADVERTISEMENT

Recent posts

Follow Me

Most popular

Most discussed